Recruiting
Phase 1
Phase 2

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

Sponsor:

National Cancer Institute (NCI)

Code:

NCT05896839

Conditions

Clinical Stage III Cutaneous Melanoma AJCC v8

Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8

Clinical Stage IV Cutaneous Melanoma AJCC v8

Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8

Metastatic Basal Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy

Biospecimen Collection

Computed Tomography

Ipilimumab

Kidney Biopsy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information